Respiratory Infections Pediatric ID Vaccines & Prevention Clinical Care & Diagnostics

Rethinking influenza vaccination opportunities

Share

Clinical Scorecard: Rethinking influenza vaccination opportunities

At a Glance

Category

Detail

Condition

Influenza vaccination in children and during pregnancy

Key Mechanisms

Antibodies generated after influenza vaccination during pregnancy can cross the placenta and help protect infants during early infancy.

Target Population

Children eligible for influenza vaccination, pregnant people, and infants younger than 6 months.

Care Setting

Pediatric health care encounters, including inpatient, emergency, subspecialty, urgent care and perioperative settings; maternal vaccination and infant illness surveillance

Key Highlights

  • Pediatric influenza vaccination coverage declined from 63.7% in 2019–2020 to 49.4% in 2025–2026, according to CDC data presented by Dr. Suchitra Rao.

  • Among undervaccinated children hospitalized with influenza across four seasons, 42% had an earlier missed vaccination opportunity at the institution that season.

  • Children’s Hospital Colorado’s standardized emergency department and perioperative programs were each associated with 15 times the odds of vaccination.

  • In the infant study presented by Samantha M. Olson, estimated effectiveness against influenza illness was 41% after maternal vaccination at or after 20 weeks’ gestation versus 25% after earlier vaccination. Only the 41% estimate was statistically significant.

Guideline-Based Recommendations

The source reports speaker recommendations, program experiences and research findings rather than a complete clinical guideline.

Diagnosis

  • The article does not provide clinical diagnostic recommendations.

  • The infant study used a test-negative design, comparing maternal vaccination status among infants with acute respiratory illness who tested positive or negative for influenza.

Management

  • Dr. Rao recommended conversational, tailored vaccine discussions rather than debates, avoiding fear-based appeals, arguments and overwhelming information.

  • Normalize vaccination and use presumptive language. If parents decline, respectfully explore their reasons and address specific concerns.

  • Ask permission before sharing information, identify shared goals and support nurses and other team members in making strong recommendations.

  • Reported program components included clinician reminders, nurse standing orders, default vaccine orders, education and electronic health record tools.

  • Olson stated that pregnant people can receive inactivated or recombinant influenza vaccines in any trimester, before or during the season.

  • Pregnant people in their third trimester can consider vaccination in July or August if vaccine is available. Olson emphasized not delaying vaccination to optimize infant timing.

Monitoring & Follow-up

  • An adaptive randomized controlled trial at 11 sites was evaluating a standardized inpatient vaccination program; results were forthcoming.

  • More research is needed to determine how earlier seasonal vaccination protects mothers and infants throughout the influenza season.

Risks

  • Reasons parents declined vaccination included safety and side-effect concerns, doubts about effectiveness, low perceived influenza risk and dislike of injections.

  • Emergency department throughput concerns were a barrier. Dr. Rao reported that offering vaccination added approximately three minutes, on average, to a visit.

  • Infants cannot receive influenza vaccination until six months of age.

Patient & Prescribing Data

The NVSN study enrolled infants younger than six months with acute respiratory illness at seven U.S. pediatric medical centers across eight influenza seasons. Maternal vaccination had to occur during pregnancy at least 14 days before delivery to count as vaccinated.

Estimated effectiveness was 44% among infants aged zero to two months and 25% among those aged three to five months; only the younger group’s estimate was statistically significant.

Effectiveness was 66% when less than four months separated maternal vaccination and infant illness, 25% at four to five months and 18% at six months or longer. Only the shortest-interval estimate was statistically significant.

An updated analysis estimated 42% effectiveness with current-season-only vaccination during pregnancy. The prior-season-only estimate was −1% and not statistically significant.

Clinical Best Practices

  • Use encounters beyond primary care to identify and vaccinate eligible children.

  • Make clear, routine vaccine offers while responding respectfully to family concerns.

  • Support vaccination through multidisciplinary teams, accessible workflows and electronic health record tools.

  • Preserve maternal protection when considering vaccination timing; the findings do not justify delaying vaccination to optimize infant protection.

Related Resources & Content

  • Rethinking influenza vaccination opportunities — Matthew Solan — IDSA Reporter — November 2, 2026 — Source article.

  • Missed Opportunities for Influenza Vaccination Among Hospitalized Children With Influenza at a Tertiary Care Facility — Rao S, Williams JTB, Torok MR, Cunningham MA, Glodè MP, Wilson KM — Hospital Pediatrics — September 2016;6(9):513-519 — https://doi.org/10.1542/hpeds.2015-0112. PubMed

  • Emergency departments: An underutilized resource to address pediatric influenza vaccine coverage — Hart R, Feygin Y, Kluthe T, Quinn KG, Rao S, Baumer-Mouradian SH — Vaccine — Published online October 19, 2023; November 13, 2023;41(47):7026-7032 — https://doi.org/10.1016/j.vaccine.2023.10.039. PubMed

  • Effectiveness of Maternal Influenza Vaccination during Pregnancy against Medically Attended Influenza among Infants <6 Months of Age, New Vaccine Surveillance Network (NVSN), 2016-2017 through 2024-2025 Influenza Seasons — Russ S, Sahni LC, Boom JA, et al — Open Forum Infectious Diseases, conference abstract — January 11, 2026;13(suppl 1):ofaf695.009 — https://doi.org/10.1093/ofid/ofaf695.009. PMC

  • Heterogeneity in seasonal influenza vaccination opportunity and disease risk during pregnancy and in infants <6 months — Morris SE, O’Halloran A, Sundaresan D, et al — Vaccine — Published online November 1, 2025; December 5, 2025;68:127887 — https://doi.org/10.1016/j.vaccine.2025.127887.